Kurma Partners Founded 2009
Founders Thierry Laugel
Overview
Portfolio analytics
Team
Investments
News & Media
Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 33
Average round size
info
The average size of a deal this fund participated in
$21M
Portfolio companies 33
Rounds per year 2.75
Lead investments 26
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.44
Exits -
Key employees -
Stages of investment
Early Stage Venture
Late Stage Venture
Seed
Areas of investment
Biotechnology
Health Care
Health Diagnostics
Life Science
Pharmaceutical
Summary

In 2009 was created Kurma Partners, which is appeared as VC. The venture was found in Europe in France. The main office of represented VC is situated in the Paris.

The fund was created by Thierry Laugel. The overall number of key employees were 6.

The usual cause for the fund is to invest in rounds with 4-5 partakers. Despite the Kurma Partners, startups are often financed by Ysios Capital, Wilco, Bpifrance. The meaningful sponsors for the fund in investment in the same round are Paris-Saclay Seed Fund, Bpifrance, Idinvest Partners. In the next rounds fund is usually obtained by Bpifrance, Life Sciences Partners, Ysios Capital.

The top activity for fund was in 2017. Despite it in 2019 the fund had an activity. The fund is generally included in 2-6 deals every year. The higher amount of exits for fund were in 2018. Comparing to the other companies, this Kurma Partners performs on 19 percentage points less the average number of lead investments. The common things for fund are deals in the range of 10 - 50 millions dollars. Speaking about the real fund results, this VC is 54 percentage points more often commits exit comparing to other organizations.

The fund has no exact preference in some founders of portfolio startups. If startup sums 5+ of the founder, the chance for it to be financed is low. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - France. Among the most successful fund investment fields, there are Therapeutics, Medical Device. Among the most popular portfolio startups of the fund, we may highlight AM Pharma, Minoryx Therapeutics, Dynacure.

Read more
Latest deals
CompanyIndustryRoundRound SizeDateInvestorsLocation
Alizé Pharma
Biotechnology
Health Care
Medical
Pharmaceutical
Wellness
Series A
67M31 Jul 2019 France, Écully
Xeltis
Health Care
Medical Device
Therapeutics
Series B
3M17 Dec 2015 Switzerland, Zurich
Xeltis
Health Care
Medical Device
Therapeutics
Series C
45M15 Nov 2017 Switzerland, Zurich
Pharvaris
Biotechnology
Life Science
Pharmaceutical
Series A
15M01 Jan 2016 Switzerland, Zug
Orphazyme
Biotechnology
Genetics
Health Diagnostics
Therapeutics
Post-IPO Equity
80M24 Nov 2017 Denmark, Copenhagen
Xeltis
Health Care
Medical Device
Therapeutics
Series B
27M02 Dec 2014 Switzerland, Zurich
Stilla Technologies
Biotechnology
Genetics
Series B
20M11 Feb 2020 France, Villejuif
OxThera
Biotechnology
Health Care
Health Diagnostics
Venture - Series Unknown
8M16 Apr 2014 Sweden, Stockholm
Advanced Perfusion Diagnostics
Biotechnology
Health Care
Information Technology
Manufacturing
Medical
Medical Device
Series A
2M10 Nov 2016 France, Villeurbanne
BliNK Biomedical
Biotechnology
Life Science
Pharmaceutical
Series A
4M11 Dec 2014 France, Lyon
Review
  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Kurma Partners?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Crunchbase icon

Content report

The following text will be sent to our editors: